Emily Pei-Ying Lin MD, PhD

Pulmonary Medicine

SPECIALTY/PRACTICE AREAS：
• Thoracic Oncology
• Precision thoracic oncology, genomics and molecular biology
• Chest medicine
LANGUAGES SPOKEN：
• English
• Chinese

 

PROFESSIONAL EDUCATION：

• MD: College of Medicine, Taipei Medical University, Taipei, Taiwan (2003)
• PhD: Taiwan International Graduate Program in Molecular Medicine, National Yang-Ming University and Academia Sinica Taiwan (2015)

 

ADMINSTRATIVE APPOINTMENTS：

• Attending Physician, Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan (2015-2019)
• Adjunct Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (2008-2019)
• Adjunct attending physician, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan (2015-2018)
• Visiting Scholar, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA (2018-2020)
• Assistant Professor, Fu Jen Catholic University School of Medicine (2020)
• Adjoint Assistant Professor, Vanderbilt University School of Medicine (2020- )

 

PUBLICATIONS：

• Wang M, Lin EP, Huang LC, Li CY, Shyr Y, Lai CH. Mortality of cardiovascular events in COPD patients with preceding hospitalized acute exacerbation. Chest. 2020;158:973-985. (Co-first)
• Das S, Ciombor KK, Haraldsdottir S, Pumpalova Y, Sahin IH, Pineda G, Shyr Y, Lin EP, Hsu CY, Chu SK, Goff LW, Cardin DB, Bilen MA, Fisher GA, Wu C, Berlin J. Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration- Approved Indications for Immunotherapy. Oncologist. 2020;25:669-679.
• Lai WY, Wang JW, Huang BT, Lin EP, Yang PC. A novel TNF--targeting aptamer for TNF--mediated acute lung injury and acute liver failure. Theranostics. 2019;9:1741–1751. (Co-corresponding)
• Lin EP, Hsiao TH, Lu JY, Wong SH, Lu TP, Peck K, Takashi T, Yang PC. Translating Gene Signatures into a Pathological Feature: Tumor Necrosis Predicts Disease Relapse in Operable and Stage I Lung Adenocarcinoma. JCO Precision Oncology. 2018. DOI: 10.1200/PO.18.00043.
• Lin EP, Lin CH, Yang CY, Lu TP, Chang SN, Hsiao TH, Huang BT, Yu CJ, Chan KA, Yang PC. Population-Based Cohort Study Reveals Distinct Associations Between Female Lung Cancer and Breast Cancer in Taiwan. JCO Clinical Cancer Informatics. 2018. DOI: 10.1200/CCI.18.00065.
• Huang BT, Lai WY, Chang YC, Wang JW, Yeh SD, Lin EP, Yang PC. A CTLA-4 antagonizing DNA aptamer with antitumor effect. Mol Ther Nucleic Acids 2017;8:520-528. (Co-corresponding)
• Lin PY, Chen HY, Yu SL, Yang PC. Turning Diversity toward Precision. J Natl Cancer Inst. 2017;109:1-2.
• Lai WY, Huang BT, Wang JW, Lin PY, Yang PC. A Novel PD-L1-targeting Antagonistic DNA Aptamer with Antitumor Effects. Mol Ther Nucleic Acids. 2016;5:e397. (Co-corresponding)
• Lin PY, Lin CH, Yang PC. Factors in Association Between Parkinson Disease and Risk of Cancer in Taiwan-Reply. JAMA Oncology. 2016;2:145-6.
• Lin CW, Lin PY, Yang PC. Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition. Stem Cells Int. 2016;2016:2732705.
• Lin PY, Chang SN, Hsiao TH, Huang BT, Lin CH, Yang PC. Association Between Parkinson Disease and Risk of Cancer in Taiwan. JAMA Oncology. 2015;1:633-40.
• Hsiao TH, Chen HI, Lu JY, Lin PY, Keller C, Comerford S, Tomlinson GE, Chen Y. Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma. Transl Cancer Res. 2013;2:6-17.
• Lin PY and Yang PC. Circulating miRNA signature for early diagnosis of lung cancer. EMBO Mol Med. 2011;3:436-7.
• Lin PY, Yu SL and Yang PC. MicroRNA in lung cancer. Br J Cancer. 2010;103:1144- 8.
• Lin PY, Chang YC, Chen HY, Chen CH, Tsui HC, Yang PC. Tumor size matters differently in pulmonary adenocarcinoma and squamous cell carcinoma. Lung Cancer. 2010;67:296-300.
• Wang CY, Wang HC, Li JM, Wang JY, Yang KC, Ho YK, Lin PY, Lee LN, Yu CJ, Yang PC, Hsueh PR. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Microbiol Immunol Infect. 2010;43:491-7.
• Lin PY, Wang JY, Hsueh PR, Lee LN, Hsiao CH, Yu JC, Yang PC. Lower gastrointestinal tract tuberculosis: an important but neglected disease. Int J Colorectal Dis. 2009;24:1175-80.
• Lin PY, Yu CJ, Yao M, Ku SC, Lee LN, Yang PC. A patient with bronchiectasis presented with progressive dyspnea and an unresolved right lower lung infiltrate. Thorax. 2008;63:876, 932.
• Lin PY, Chen JS, Ku SC, Wu MZ, Yu CJ, Yang PC. A 50-year-old man with bilateral pulmonary tumours. Thorax. 2008;63:193, 239.
• Lin PY, Lee TC, Liu KL, Sung CD, Lin JT, Wang HP. Nautilus-patterned Small Intestines. Gut. 2008;57:1073, 1082.
• Lin PY, Shih JY, Wu MZ, Chang YT, Yang PC. Extensive GI tract involvement of Ewing's sarcoma/peripheral primitive neuroectodermal tumor in an octogenarian. Gastrointest Endosc. 2008;67:1196-8.
• Lin PY, Kuo PH, Yu CJ, Yang PC. Long-term remission of hepatic hydrothorax after OK-432 pleurodesis. J Thorac Cardiovasc Surg. 2008;136:1367-9.
• Lin PY, Tsai MS, Chang JH, Chen WJ, Huang CH. Gastric distension: a risk factor of pneumoperitoneum during cardiopulmonary resuscitation. Am J Emerg Med. 2006;24:878-879.